好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2025 Annual Meeting | C31 - Harnessing Artificial Intelligence to Enhance Clinical Practice and Neurology's Future

Saturday 04/05/25
02:30 PM - 04:30 PM PDT Add To Calendar
San Diego Convention Center | 29A
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Mark Mintz, MD, FAAN
Practice, Policy, and Ethics
AI has shown promise for augmenting neurological expertise, alleviating the burden of repetitive tasks, data collection, report preparation and scribing, and stratifying disease risk. Participants should gain an overall understanding of the types of AI and machine learning; present and potential future clinical applications of AI, including benefits and challenges that AI creates for neurologists; and the future of neurological care utilizing AI.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Quality Improvement
Introductory
Artificial Intelligence, Advanced Practice Provider, Quality and Safety
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator
Didactic, Audience Participation, Other

Program Materials

Event Timeline
02:30 PM - 02:40 PM PDT Speaker Harnessing AI to Enhance Clinical Practice and Neurology’s Future
Mark Mintz, MD, FAAN
02:40 PM - 02:55 PM PDT Speaker The AI Neurologist
Daniel Goldenholz, MD, PhD
02:55 PM - 03:15 PM PDT Speaker Demo: Ambient AI For Clinical Report Generation
Wesley Kerr, MD, PhD
03:15 PM - 03:25 PM PDT Speaker Prompting Techniques to Optimize the Clinical Utility of AI
Braydon Dymm, MD
03:25 PM - 03:35 PM PDT Speaker Demo: Customizing AI for Clinical Use
Braydon Dymm, MD
03:35 PM - 03:50 PM PDT Speaker AI vs. Human Intelligence, Microchips vs. Brains: Similarities and Differences
Sankar Bandyopadhyay, MD, FAAN
03:50 PM - 04:05 PM PDT Speaker Demo: Using AI for Diagnosis, Treatment, Prevention and Prediction
Judith Dexheimer
04:05 PM - 04:30 PM PDT Discussion Panel Discussion
Mark Mintz, MD, FAAN
Faculty Disclosures
Mark Mintz, MD, FAAN Dr. Mintz has nothing to disclose.
Sankar Bandyopadhyay, MD, FAAN Dr. Bandyopadhyay has nothing to disclose.
Daniel Goldenholz, MD, PhD Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuro Event Labs. Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving as a Consultant for IDR. Dr. Goldenholz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Livanova . Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving as a Consultant for Health Advances . Dr. Goldenholz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AAN. Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ACNS. Dr. Goldenholz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AES. Dr. Goldenholz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Nebraska Neurological Society . The institution of Dr. Goldenholz has received research support from NIH. The institution of Dr. Goldenholz has received research support from BIDMC. Dr. Goldenholz has a non-compensated relationship as a advisor with Eysz that is relevant to AAN interests or activities. Dr. Goldenholz has a non-compensated relationship as a advisor with Epilepsy AI that is relevant to AAN interests or activities.
Braydon Dymm, MD Dr. Dymm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AvoMD. Dr. Dymm has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Glass Health.
Wesley Kerr, MD, PhD Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Lifesciences. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EpiTel. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kerr has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerebral Therapeutics. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. The institution of Dr. Kerr has received research support from NINDS. The institution of Dr. Kerr has received research support from American Epilepsy Society. The institution of Dr. Kerr has received research support from 好色先生. Dr. Kerr has received publishing royalties from a publication relating to health care.
Judith Dexheimer No disclosure on file